Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Aug 28, 2026

LBRX — LB Pharmaceuticals Inc Dilution Risk Tracker

Track LBRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LBRX — Get alerts when the score changes →

As of August 28, 2026, LB Pharmaceuticals Inc (LBRX) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. LB Pharmaceuticals Inc has a market capitalization of $802.09M, 32.26M shares outstanding, 77 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $100.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
62
💰 Cash Runway
0
📊 Float Risk
50
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 10%
💰 Capital Raise model 20%
• Active shelf registration ($100M, 12% of market cap)
🔔 Track LBRX — Get forecast alerts →

Market Data

Market Cap$802.09M
Shares Outstanding32.26M
Float18.10M
Cash$327.79M
Debt$3.47M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 22.1% shares (2026Q1 vs prior)
77 institutional holders · 30.39M shares
#1 Deep Track Capital, LP 3.35M shares
#2 BlackRock, Inc. 2.47M shares
#3 RA CAPITAL MANAGEMENT, L.P. 2.21M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.75M
Days to Cover12.8
% of Float26.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
424B3 ATM 2026-04-14
EFFECT EFFECT 2026-04-14
S-1 SHELF 2026-04-06
4 INSIDER TRANSACTION 2026-03-10
Full SEC filing analysis available with free account

Recent News

No recent news

Factual LBRX Dilution Snapshot

LB Pharmaceuticals Inc (LBRX) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track LBRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LBRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LBRX
LBRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.